INTRODUCTION:

Gastric purging of measurement structures is an amazingly variable methodology and capability to draw out and control discharging time is important holding for measurements structures, which live in the stomach for a more extended time than routine measurement structures. A few troubles are confronted in outlining controlled discharge frameworks for better retention and upgraded bioavailability. One of such troubles is the powerlessness to keep the dose structure in the craved range of the gastrointestinal tract. Drug retention from the gastrointestinal tract is a complex system and is liable to numerous variables.

It is generally recognized that the degree of gastrointestinal tract drug assimilation is identified with contact time with the little intestinal mucosa.^[^1] Thus little intestinal travel time is a parameter for medications that are deficiently assimilated. Gastroretentive frameworks can stay in the gastric locale for a few hours and consequently essentially delay the gastric living arrangement time of medications. Delayed gastric maintenance enhances bioavailability, decreases medication squander and enhances dissolvability for medications that are less dissolvable in a high the earth. It has applications additionally for nearby medication conveyance to the stomach and proximal little intestines. Gastroretention serves to give better accessibility of new items with new restorative potential outcomes and significant profits for patients. These frameworks are likewise invaluable in enhancing GIT retention of medication having slender assimilation windows and site particular ingestion confinements. These frameworks are valuable in the event of those medications which are best invested in stomach for e.g. Albuterol. Thus, this audit article concentrates on the simultaneous mechanical improvements and headways in gastroretentive medication conveyance framework with exceptional attention on the methodologies and the points of interest of gastroretentive drug delivery system. The uniform appropriation of the skimming microspheres along the gastrointestinal tract could bring about more reproducible medication assimilation and decreased danger of neighborhood disturbance. This conceived oral controlled medication conveyance and prompted advancement of gastroretentive floating microspheres.^[2]

Basic Gastrointestinal Tract Physiology:-

Anatomically the stomach is isolated into 3 areas: fundus, body, and antrum (pylorus).

The proximal part made of fundus and body goes about as a repository for undigested material, while the antrum is the principle site for blending movements and goes about as a pump for gastric exhausting by pushing activities.^[3] Gastric discharging happens amid fasting and also sustained states. The example of motility is however different in the 2 states. Amid the fasting express an interdigestive arrangement of electrical occasions happen, which spin both through stomach and digestive tract each 2 to 3 hrs. This is known as the interdigestive myloelectric cycle or relocating myloelectric cycle (MMC), which is further partitioned into emulating 4 stages as depicted by Wilson and Washington. ^[4]

1. Stage i (basal stage) keeps going from 40 to 60 minutes with uncommon compressions.

2. Stage ii (preburst stage) goes on for 40 to 60 minutes with discontinuous activity potential what's more compressions. As the stage advances the force and recurrence additionally increments slowly.

3. Stage iii (blast stage) goes on for 4 to 6 minutes. It incorporates extraordinary and consistent compressions for brief time. It is because of this wave that all the undigested material is cleared out of the stomach down to the small digestive tract. It is otherwise called the servant wave.

4. Stage iv goes on for 0 to 5 minutes and happens between stages III and I of 2sequential cycles. ^[21]

After the ingestion of a blended supper, the example of constrictions progressions from fasted to that of bolstered state. This is otherwise called digestive motility design and involves constant constrictions as in stage II of fasted state. These compressions result in diminishing the extent of nourishment particles (to short of what 1 mm), which are pushed around the pylorus in a suspension structure. Amid the nourished state onset of MMC is deferred bringing about stoppage of gastric exhausting rate. Scintigraphic studies deciding gastric purging rates uncovered that orally managed controlled discharge dose structures are subjected to fundamentally 2 intricacies that of short gastric home time and flighty gastric discharging rate. ^[5]

Fig. No.1- GI Motility Pattern [56]

Factors affecting gastroretention:-

The gastric maintenance time of measurements structure is controlled by a few components that influence their adequacy as a gastroretentive framework. ^[6]

Density:

Gastric retention time (GRT) is a capacity of measurements structure lightness that is reliant on the thickness.

Size:

Measurements structure units with a breadth of more than 9.5mm are accounted for to have an expanded GRT.

State of measurements form:

Tetrahedron and ring-formed gadgets with a flexural modulus of 48 and 22.5 kilo pounds for every square crawl (KSI) are accounted for to have better gastric retention time. 90% to 100% maintenance at 24 hours contrasted and different shapes.

Single or different unit formulation:

Different unit details demonstrate a more unsurprising discharge profile and unimportant impeding of execution because of disappointment of units, permit co organization of units with diverse discharge profiles or containing contradictory substances and grant a bigger edge of security against measurement structure disappointment contrasted and single unit dose structures.

Sustained or unfed state:

Under fasting conditions, the GI motility is described by times of solid engine movement or the moving myloelectric complex (MMC) that happens each 1.5 to 2 hours. The MMC ranges undigested material from the stomach and, if the timing of organization of the detailing agrees with that of the MMC, the GRT of the unit might be required to be short. Then again, in the encouraged state, MMC is deferred and GRT is impressively more. ^[7]

Nature of meal:

Sustaining of inedible polymers or unsaturated fat salts can change the motility example of the stomach to a sustained state, in this way diminishing the gastric discharging rate and delaying medication discharge.

Caloric content:

GRT could be expanded by four to 10 hours with a dinner that is high in proteins and fat. ^[8]

Recurrence of feed:

The GRT can increment by in excess of 400 minutes when progressive suppers are given contrasted with a solitary dinner due with the low recurrence of MMC.^[^9]

Gender– Mean wandering GRT in guys (3.4hours) is less contrasted and their age furthermore race-matched female partners (4.6hours), paying little mind to the weight, tallness and body surface.

Age:

Elderly individuals, particularly those in excess of 70, have an altogether more GRT. ^[10]

Posture– GRT can differ in the middle of prostrate and upright wandering states of the patient.

Why Gastroretentive drug delivery?

Drugs which are effortlessly assimilated from the gastrointestinal tract and those with short half lives are immediately killed from the systemic flow because of which continuous dosing is needed. To beat this issue, gastroretentive medication conveyance frameworks which give compelling plasma drug focus to longer periods along these lines lessening the dosing recurrence are continuously defined. It additionally has leverage of minimizing the vacillations in plasma drug focus by conveying the medication in a controlled and reproducible way. ^{[1, 11, 12]}

Need for Gastro Retention: -

- Medicates that are retained from the proximal piece of the gastrointestinal tract (GIT). - Drugs that are less solvent or that corrupt by the antacid ph they experiences at the lower a piece of GIT.

- Drugs that are retained because of variable gastric exhausting time.

- Local or supported medication conveyance to the stomach and proximal Small digestive system to treat certain conditions.

- Particularly valuable for the treatment of peptic ulcers created by H. Pylori infection. ^[13]

Advantages:-

1. Used for neighborhood activity in the stomach.

2. In the treatment of peptic ulcer illness.

3. Used for the conveyance of medications with restricted assimilation window in the small digestive system.

4. Reduced dosing recurrence.

5. Improved bioavailability of the medication.

6. Used for medications which are precarious in intestinal liquids.

7. Used to support the conveyance of medication.

8. Used for keeping up the systemic medication fixation inside the helpful window.

9. Site particular medication conveyance is likewise conceivable. ^[14,
15]

Disadvantages:-

1. These require sufficiently large amounts of stomach liquids, for the framework to float and to work effectively.

2. Not suitable for medications with dependability or solvency issue in stomach.

3. Drugs which experience broad first pass digestion system are not suitable competitors.

4. Drugs with aggravation impact additionally restrain the materialness. ^[15]

Requirements for the gastroretentive formulations:-

1. It must structure a firm gel obstruction to encourage maintenance.

2. It must keep up particular gravity lower than gastric substance.

3. It ought to discharge substance gradually to serve as a store.

4. Selection of excipients is an essential vital choice for outlining a dosage structure with consistence and controlled habitation in the stomach. ^[16]

Limitations of floating drug delivery system:-

1. An abnormal state of liquid in the stomach is needed for medication conveyance to float and work effectively.

2. Drugs which have security and dissolvability issues in GIT are not suitable competitors for these sorts of frameworks. ^[17]

3. Medications, for example, nifedipine, which under goes first pass digestion system may not be attractive for the readiness of these sorts of frameworks. ^[18]

4. Drugs which are aggravation to gastric mucosa are likewise not attractive.

5. The medication substances those are insecure in the acidic environment of the stomach are not suitable hopefuls to be consolidated in the frameworks. ^[19]

Formulation considerations for FGRDDS:-

- It must be viable maintenance in the stomach to suit for the clinical interest

1) It must have sufficient medication stacking limit.

2) It must be control the medication discharge profile.

3) It must have full debasement and departure of the framework once the medication discharge is over.

4) It ought not to have impact on gastric motility including discharging example.

5) It ought not to have other neighborhood antagonistic impacts. ^[20,
21]

Drug Candidates Suitable for Floating Gastroretentive Drug Delivery:-

Drugs which have site-particular assimilation in the stomach or upper parts of the small digestive system (furosemide, riboflavine-5- phosphate), drugs needed to push neighborhood helpful activity in the stomach (antacids, hostile to H.pylori operators, misoprostol), drugs shaky in the lower piece of Gastro-intestinal tract (captopril), drugs insoluble in intestinal liquids (quinidine, diazepam), drugs with variable bioavailability (Satolol HCl).^{[22, 23]}

Approaches to design FGRDDS:-

Practical approaches in designing FGRDDS:

The idea of FGRDDS was initially portrayed in the writing as right on time as 1968, when Davis (1968) uncovered a strategy to beat the trouble accomplished by a few persons of choking or gagging in the wake of gulping therapeutic pills. The creator proposed that such trouble could be overcome by giving pill having a thickness of short of what 1.0g/cm3, so pill will glide on water surface. From that point forward a few methodologies have been utilized to create a perfect coasting medication conveyance framework. ^[27]

Approaches to design single and multiple unit dosage form:

The accompanying methodologies have been utilized for the configuration of drifting dose manifestations of single and numerous unit frameworks. ^[24-
26]

For single unit dosage forms (e.g.: tablets):

(i) Floating slack time: It is the time taken by the tablet to rise onto the surface of disintegration medium and is communicated in seconds or minutes.

(ii) In vitro medication discharge and span of floating: This is dictated by utilizing USP II contraption (oar) mixing at a pace of 50 or 100 rpm at 37 ± 0.2°C in reproduced gastric liquid (ph 1.2 without pepsin). Aliquots of the specimens are gathered and investigated for the medication content. The time (hrs) for which the tablets stay light on the surface of the disintegration medium is the span of drifting and is outwardly watched.

(iii) In vivo assessment for gastro-maintenance: This is completed by method for Xbeam or Gamma scintigraphic observing of the measurements structure move in the GIT. The tablets are additionally assessed for hardness, weight variety, and so forth. In low thickness approaches, the globular shells clearly having lower thickness than that of gastric liquid can be utilized as a transporter like popcorn, polystrol for the medication for its controlled discharge. The polymer of decision can be either Ethyl cellulose or HPMC. Contingent upon sort of discharge coveted. At last the item drifts on the gastric liquid while discharging the medication step by step over a delayed term. Liquid filled drifting chamber kind of dose structures incorporates consolidation of a gas filled floatation chamber into a micro permeable part that houses as a store having openings present at top and bottom dividers through which the gastrointestinal tract liquid enters to break up the medication. ^[28]

Hydro dynamically balanced system (HBS):

These frameworks are intended to drag out the stay of the dose structures in the gastric intestinal tract and support in improving the retention. Medications having a finer solvency in acidic environment furthermore having particular site of retention in the upper part of small digestive tract is attained by these HBS frameworks. To hold in stomach for a delayed time of time the dose structure must have mass thickness of short of what "1" and need to keep up its structural trustworthiness and discharge medicate continually from the measurement structure. Among all the points of interest single-unit details are connected with a few restrictions/issues, for example, staying together or being impeded in the GIT which may prompt potential peril of creating disturbance. ^[29]

For multiple unit dosage forms (e.g.: microspheres):-

Separated from the In vitro discharge, length of time of drifting and in vivo gastro maintenance tests, the different unit measurements structures are also assessed for:

(i) Morphological and dimensional dissection with the help of checking electron microscopy (SEM). The size can likewise be measured utilizing an optical magnifying lens.

(ii) In vitro drifting capacity (Buoyancy %): A known amount of microspheres are spread over the surface of a USP (Type II) disintegration contraption loaded with 900 ml of 0.1 N Hcl containing 0.002% v/v Tween 80 and disturbed at 100 rpm for 12 hours.

Following 12 hours, the drifting and settled layers are separated, dried in a dessicator and weighed. The lightness is figured from the accompanying equation.

Buoyancy (%) = Wf / (Wf + Ws) x 100

Where,

Wf and Ws are the weights of floating and settled microspheres separately.

(iii) Drug-excipient (DE) associations: This is carried out utilizing FTIR. Appearance of another top, and/or vanishing of unique medication or excipient crest show the DE association. Separated from the aforementioned assessment parameters, granules are additionally assessed for the impact of maturing with the assistance of Differential Scanning Calorimeter or Hot stage polarizing microscopy. Multiparticulate dose structures are picking up much support over single unit measurement structures. The potential profits incorporate expanded bioavailability; unsurprising, reproducible and by and large short gastric habitation time, no danger of measurements dumping; decreased danger of neighborhood aggravation, and the adaptability to mix pellets with diverse arrangements or discharge designs. Due to their littler molecule estimate these frameworks are equipped for passing through the GI tract effectively, prompting less between and intra-subject variability. ^[30]On the other hand, potential medication stacking of a Multiparticulate framework is lower in light of the relatively higher requirement for excipients (e.g., sugar centers). Most Multiparticulate Pulsatile conveyance frameworks are store gadgets covered with a respectable polymeric layer. Upon water entrance, medication is discharged from the center in the wake of cracking of the encompassing polymer layer, because of weight construct up inside the framework. The weight important to break the covering can be accomplished with swelling executors, gas delivering fizzing excipients or expanded osmotic weight. Water penetration and mechanical safety of the external film are main considerations influencing the slack time. Water dissolvable medications are chiefly discharged by dispersion; while for water insoluble medication, the discharge is subject to disintegration of medication. ^[31]

Evaluation:-

(A) In vitro evaluation

(i) Floating systems

(a) Buoyancy lag time

(b) Floating time

(d) Resultant weight

(ii) Swelling systems

(a) Swelling index

(b) Water uptake

(B) In vitro dissolution tests

(C) In vivo evaluation

i) Radiology

ii) ⊥-scintigraphy

iii) Gastroscopy

iv) Magnetic marker monitoring

v) Ultrasonography

A) In vitro evaluation

(i) Floating systems

(a) Buoyancy lag time:

It is dead set to survey the time taken by the measurement structure to buoy on the highest point of the disintegration medium, after it is put in the medium. These parameters can be measured as a piece of the disintegration test.

(b) Floating time:

Test for lightness is generally performed in SGF-Simulated Gastric Fluid kept up at 37⁰C. The time for which the measurement structure constantly skims on the disintegration media is termed as floating time.

(c) Specific gravity/density:

Thickness can be controlled by the relocation technique utilizing Benzene as uprooting medium.

(d)Resultant weight:

Now, we realize that mass thickness and skimming time are the primary parameters for depicting lightness. Be that as it may just single determination of thickness is not sufficient to portray the lightness on the grounds that thickness changes with change in resultant weight as a capacity of time. For instance a grid tablet with bicarbonate and matrixing polymer skims at first by gas era and capture however after at some point, some medication is discharged and at the same time some external piece of matrixing polymer may dissolve out prompting change in resultant weight of measurement structure.

F = Fbuoy–Fgrav,

F = Df g V – Ds g V,

F = (Df – Ds) g V,

F = (Df – M/V) g V

Where,

F = Resultant weight of object

Df = Density of liquid

Ds = Density of robust object

g = Gravitational power

M = Mass of measurements structure

V = Volume of measurements structure

- So when Ds, thickness of measurements structure is lower, F energy is sure gives lightness and when it is Ds is higher, F will negative shows sinking. ^[32]

(ii) Swelling systems:-

(a) Swelling index:

After drenching of swelling dose structure into SGF at 370c, measurements structure is evacuated out at general interim and dimensional progressions are measured regarding increment in tablet thickness/width with time.

(b) Water uptake:

It is a backhanded estimation of swelling property of swellable framework. Here measurement structure is uprooted out at standard interim and weight progressions are resolved as for time. So it is additionally termed as Weight Gain.

Water uptake = WU = (Wt – Wo) * 100 / Wo

Where,

Wt = Weight of dose structure at time t

Wo = Initial weight of dose structure

- In this get together concentric rings with different widths are attracted machine and print out is overlaid to make hydrophobic. This covered piece is joined with some framework which can encourage all over development of get together.

- This gathering is set in measuring utencil and tablet is put precisely at focus and after that there is no aggravation given to tablet.

- Tablet is permitted to swell on overlaid paper and width can be effectively noted without uprooting out.

- To focus water uptake/weight pick up, entire gathering can bring out. Weighing of get together done in the wake of wiping off water droplets followed at surface of gathering and afterward can be set once again as it is without touching to tablet. ^[33]

(c) Continuous monitoring of water uptake: -

Albeit past strategy has point of interest of un-unsettling influence of swollen tablet, yet for measuring water uptake one need to evacuate entire get together out of recepticle, so handle in not persistent.

- Persistent checking of water uptake is conceivable by taking after contraption.

- In this device, swelling tablet is put on glass channel as backing in one honor barrel with smooth surface inside, and one light weight punch is put on it to avert floating.

- This barrel is put preheated in disintegration medium.

- An alternate disintegration medium supply recepticle is put on computerized offset and both are joined with media filled U tube as demonstrated in figure and medium level is kept equivalent.

- As swelling of tablet began, it retains water and water level in external piece of chamber is goes down.

- The reduction in water level is kept up by importing additional medium by means of U tube from repository recepticle.

- As medium is exchange from store, measure of water exchange can be controlled by watching misfortune in weight by advanced parity. ^[34]

B) In vitro dissolution tests:-

A. In vitro disintegration test is by and large done by utilizing USP device with oar and Gastroretentive drug delivery system is set ordinarily concerning other traditional tablets. Yet now and again as the vessel is huge and oars are at bottom, there is much lesser oar power follows up on drifting measurement structure which by and large buoys on surface. As floating measurement structure not pivots may not give legitimate come about furthermore not reproducible results. Comparative issue happen with swellable measurements structure, as they are hydrogel may adhere to surface of vessel or oar and gives irreproducible results. In request to counteract such issues, different sorts of alteration in disintegration get together made are as takes after.

B. To anticipate staying at vessel or paddle and to enhance development of measurements structure, technique recommended is to keep paddle at surface and not very profound inside disintegration medium.

C. Coasting unit can be made completely submerged, by joining some little, detached, non responding material, for example, few turns of wire helix, around measurement structure. However this system can hinder three dimensional swelling of some measurements structure furthermore influences medication discharge.

D. Other change is to make skimming unit completely submerged under ring or work get together and oar is just over ring that gives better compel for development of unit.

E. Other strategy recommends putting dose structure between 2 ring/cross sections.

F. In past strategies unit have little region, which can repress 3d swelling of swellable units, an alternate system recommend the change in disintegration vessel that is indented at some above spot from base and lattice is place on indented bulges, this gives more range for measurement structure.

G. Inspite of the different changes done to get the reproducible results, none of them demonstrated corelation with the in vivo conditions. So a novel disintegration test device with adjustment of Rossett-Rice test Apparatus was proposed. Rossett-Rice test is utilized for anticipating as a part of vitro assessment of straightforwardly acting acid neutralizer (activity by synthetic balance of corrosive), where HCl is added bit by bit to copy the discharge rate of corrosive from the stomach. ^[35]

C) In vivo evaluation:-

(a) Radiology:

X-beam is generally utilized for examination of inward body frameworks. Barium Sulfate is broadly utilized Radio Opaque Marker. Along these lines, BaSO₄ is consolidated inside measurements structure and X-beam pictures are taken at different interims to view gastroretention.

(b) ⊥-scintigraphy:

Similar to X-beam, ⊥-transmitting materials are joined into measurement structure and after that pictures are taken by scintigraphy. Generally utilized ⊥-transmitting material is 99tc.

(c) Gastroscopy:

Gastroscopy is peroral endoscopy utilized with fiber optics or feature frameworks. Gastroscopy is utilized to review outwardly the impact of prolongation in stomach. It can likewise give the nitty gritty assessment of gastroretentive drug delivery system.

(d) Magnetic marker observing:

In this method, measurements structure is attractively checked with joining iron powder inside, and pictures can be taken by exceptionally delicate bio-attractive estimation supplies. Playing point of this technique is that it is radiation less along these lines not unsafe. ^[36]

(e) Ultrasonography:

Used here and there, not utilized for the most part in light of the fact that it is not traceable at intestine. ^[37]

Drugs used in FGRDDS:-

Table 1:- Drugs used in FGRDDS _[38-
41]

Sr. no.	Dosage form	Drug
1.	Microspheres	Ketoprofen Aspirin Griseofulvin Ibuprofen Terfenadine Verapamil
2.	Tablets/Pills	Riboflavin Acetoaminophen Aspirin Ampicillin Captopril
3.	Granules	Indomethacin Prednisolone Diclofenac sodium Fluorouracil
4.	Capsules	Furosemide Diazepam Misoprostol Nicardipine
5.	Films	Cinnarazine Piretanide Prednisolone Quinidine gluconate

Polymers used in FGRDDS:-

Table 2:- Polymers used in FGRDDS ^[42]

Sr.no.	Synthetic polymer	Natural polymer
1.	Polymethyl methacrylic acid	Gellan gum
2.	Polymethacyclic acid	Okra gum
3.	Polycarbonates	Chitosan
4.	Polyamides	Guar gum
5.	Polyvinyl alcohol	Carragenan
6.	Carbopol 934	Gelatin
7.	HPMC K 100M	Tragacanth
8.	HPMC K 15M	Pectin
9.	HPMC K4M	Sodium alginate

Applications:-

Coasting medication conveyance offers a few applications for medications having poor bioavailability due to the slender retention window in the upper piece of the gastrointestinal tract. It holds the measurements structure at the site of retention and in this manner upgrades the bioavailability. These are compressed as takes after.

1) Sustained drug delivery:

HBS frameworks can stay in the stomach for long periods and subsequently can discharge the medication over a prolonged time. The issue of short gastric living arrangement time experienced with an oral controlled release (CR) detailing thus can be overcome with these systems. These frameworks have a mass thickness of GI as an aftereffect of which they can drift on the gastric substance. These frameworks are moderately substantial in size and passing from the pyloric opening is disallowed. As of late managed discharge skimming containers of Nicardipine hydrochloride were produced also were assessed in vivo. The definition contrasted and industrially accessible MICARD containers utilizing rabbits. Plasma focus time bends demonstrated a more drawn out span for organization (16 hours) in the maintained discharge floating containers as contrasted and routine MICARD cases (8 hours). Thus a similar study, between the Madopar HBS and Madopar standard detailing was carried out and it was demonstrated that the medication was discharged up to 8 hours in vitro in the previous case and the discharge was basically finish in under 30 minutes in the last case. Oral CR plans are experienced with issues for example, gastric home time in the gastrointestinal tract. These issues can be overcome with the HBS frameworks which can stay in the stomach for long periods and have a mass thickness <1 as an aftereffect of which they can float on the gastric substance. These frameworks are moderately bigger in size and passing from the pyloric opening is precluded.

2) Site-specific drug delivery:

These frameworks are especially profitable for medications that are particularly ingested from stomach or the proximal piece of the small digestive system, e.g., riboflavin and furosemide. Furosemide is principally consumed from the stomach took after by the duodenum. It has been reported that a solid coasting measurement structure with delayed gastric home time was developed and the bioavailability was expanded. AUC got with the coasting tablets was approximately 1.8 times those of routine furosemide tablets. A bilayer floating case was created for nearby conveyance of misoprostol, which is an engineered simple of prostaglandin E1 utilized as a protectant of gastric ulcers brought on by organization of NSAIDs. By focusing on moderate conveyance of misoprostol to the stomach, fancied restorative levels could be attained and medication waste could be reduced. These frameworks are especially favorable for medications that are particularly consumed from the stomach or the proximal piece of the small digestive tract .The controlled, moderate conveyance of medication to the stomach gives sufficient nearby remedial levels and limits the systemic presentation to the medication. This decreases reactions that are created by the medication in the blood dissemination. What's more, the delayed gastric accessibility from a site guided conveyance framework might likewise decrease the dosing recurrence. E.g.: Furosemide and Riboflavin.

3) Absorption enhancement:

Medicates that have poor bioavailabilities due to site particular retention from the upper a piece of the gastrointestinal tract are potential competitors to be detailed as gliding medication conveyance frameworks, accordingly boosting their ingestion. A critical increment in the bioavailability of Floating measurements structures (42.9%) could be accomplished as contrasted and industrially accessible LASIX tablets (33.4%) and enteric covered LASIX-long item (29.5%).drugs which are having poor bioavailability on account of site particular assimilation from the upper piece of the GIT are potential applicants to be formed as floating medication conveyance frameworks, thereby boosting their ingestion.

4) Enhanced bioavailability:

The bioavailability of riboflavin CR-GRDF is essentially improved in correlation to the organization of non-GRDF CR polymeric plans. There are a few distinctive methods, identified with assimilation and travel of the medication in the gastrointestinal tract, that demonstration correspondingly to impact the extent of medication ingestion.

5) Minimized antagonistic action at the colon:

Maintenance of the medication in the HBS frameworks at the stomach minimizes the measure of medication that achieves the colon. In this manner, undesirable exercises of the medication in colon may be prevented. This pharmacodynamic perspective gives the basis to GRDF plan for betalactam anti-toxins that are retained just from the small digestive tract, and whose vicinity in the colon prompts the improvement of microorganism’s safety.

6) Reduced variances of medication focus:

Persistent data of the medication after CRGRDF organization produces blood drug focuses inside a narrower reach contrasted with the quick discharge measurement Forms. Along these lines, vacillations in medication impacts are minimized and focus subordinate unfavorable impacts that are connected with crest focuses can be averted. ^{[43, 44]}

Recent Trends:-

1. S. C. Angadi et al., created composite mix microbeads of sodium alginate (Naalg) with sodium carboxymethyl cellulose (Nacmc) containing magnesium aluminum silicate (MAS) particles and enteric covered with chitosan to attain controlled discharge (CR) of amoxicillin in stomach environment. ^[45]

2. V. Prakya et al., created controlled release mucoadhesive center tablets to restrict the tablets to the particular site in the gastrointestinal tract. A projective layer ensures the center tablets from mucoadhesion till the focused on hand is arrived at. Once the tablet achieves the particular site, the cover breaks down uncovering the center tablet for mucoadhesion. ^[46]

3. Yao, Huimin et al., created a novel sort of inward permeable gliding globules. The dabs were arranged by dribbling the froth arrangement into Cacl2 arrangement utilizing disposable syringe needle, where the froth arrangement comprising various of microbubbles with poloxamer 188 as frothing executors, alginate as frothing stabilizer. ^[47]

4. Malakar, Jadupati et al., researched the improvement, advancement and in vitro assessment of fluid paraffin-captured various unit alginate-based coasting framework containing cloxacillin by emulsion–gelation strategy for gastro retentive delivery. ^[48]

5. Nayak, Amit Kumar et al., arranged hydrodynamically adjusted frameworks (Hbss) of loxacin utilizing lactose, HPMC K4m, PVP K 30, and fluid paraffin, which may build the mean habitation time in the gastrointestinal tract, and may have the capacity to give greatest medication at the site of ingestion to enhance oral bioavailability. ^[49]

6. Mostafavi, Abolfazl et al., created a delayed discharge gastroretentive formulation of ciprofloxacin that could be regulated once every day with a customary tablet (CT). ^[50]

7. Işıklan, Nuran et al., created an arrangement of ph responsive alginate-g-poly (itaconic corrosive) (Naalg-g-PIA) microspheres as medication conveyance grids of nifedipine cross joined by glutaraldehyde (GA) in the hydrochloric corrosive impetus. Unite copolymers of sodium alginate with itaconic corrosive were blended utilizing ceric ammonium nitrate. ^[51]

8. Dorożyński, P et al., directed a study to explore the impacts of carrageenans, and hydroxypropylmethylcellulose (HPMC) on the properties of hydrodynamically adjusted frameworks (HBS) containing L-dopa as a model medication. The novel coordinated methodology included estimations of: dissolvable uptake, disintegration, obvious thickness and changes in the inside structure of dose structures amid disintegration test by method for an Usp4 perfect MR. ^[52]

9. Liandong Hu et al., created dextromethorphan hydrobromide sustained release (DMBSR) tablets utilizing coasting method to drag out the gastric living arrangement time and contrasted their pharmacokinetic conduct and traditional managed discharge tablets. ^[53]

10. Mina Ibrahim Tadros developed a gastroretentive controlled-discharge drug conveyance framework with swelling, floating, etc. ^[54]

Marketed preparations:-

Table 3- Marketed preparations of FGRDDS ^[55]

Sr.no.	Brand Name	Drug
1.	Oflin OD	Ofloxacin
2.	Cifran OD	Ciprofloxacin
3.	Cytotec	Misoprostol
4.	Topalkan	Al-Mg antacid
5.	Liquid gaviscon	Al. Hydroxide Mg. carbonate
6.	Conviron OD	Ferrous sulphate
7.	Valrelease	Diazepam
8.	Madopar	Levodopa Benserazide

Future perspective:-

Among the medications right now in clinical utilization are a few slender ingestion window medicates that may profit from aggravating into a FGRDDS. Supplanting parental administration of medications to oral pharmacotherapy would generously enhance treatment. It is expected that FGRDDS may improve this plausibility. Additionally, it is normal that the FGRDDS methodology may be utilized for a lot of people potentially dynamic executors with slender ingestion window, whose advancement has been stopped because of absence of suitable pharmaceutical FGRDDS innovations. Blend help to treat H. pylori disease in a solitary FGRDDS need to be produced. Further examination might concentrate on the accompanying idea:

1. Identification of an insignificant cut-off size over that DFS held in the human stomach for delayed time. This would allow a more particular control to be attained in gastroretentivity.

2. Design of show of FGRDDS, each one having a slender gastric retention time for utilization as indicated by the clinical need e.g. dose and condition of ailment. This may be attained by exacerbating polymeric metrics with different biodegradation properties.

3. Study of the impact of different geometric shape, in a more extreme way than past studies, expanded measurements with high unbending nature, on gastroretentivity.

4. Design of novel polymers as per clinical and pharmaceutical need.

CONCLUSION:

Drug retention in the gastrointestinal tract is an exceedingly variable strategy and drawing out gastric maintenance of the measurements structure augments the time for medication assimilation. Gastro-retentive skimming medication conveyance frameworks have developed as a productive means of upgrading the bioavailability and controlled conveyance of numerous drugs. The expanding complexity of conveyance innovation will guarantee the advancement of expansion number of gastroretentive medication conveyance to advance the conveyance of atoms that show ingestion window, low bioavailability and broad first pass digestion system. FDDS guarantees to be a potential methodology for gastric maintenance. In spite of the fact that there are number of troubles to be lived up to expectations out to attain delayed gastric maintenance, countless organizations are centering to commercializing this method.

REFERENCES:

1. Hirtz J. The GIT absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol, 1985; 19:77-83.

2. Amnon Hoffman, David Stepensky, Eran Lavy, Sara Eyal, Eytan Klausner, Michael Friedman. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int J Pharm 2004; 141-153.

3. Desai S. A Novel Floating Controlled Release Drug Delivery System based on a Dried Gel Matrix Network [master’s thesis].1984 Jamaica, NY, and St John’s University.

4. Vantrappen GR, Peeters TL, Jassens J. The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol.1979; 14:663-667.

5. Wilson CG, Washington N. The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological Pharmaceutical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood; 1989:47-70.

6. G. Sanjay and S. Sharma (2003). Business Briefing Pharmtech.

7. L.J. Caldwell, R.C. Gardner and R.C. Cargill (1988). US Patent: 4,735,804.

8. M. Marvola, A. Kannikoski, H. Aito and S. Nykanen Int. J. Pharm 1989; Vol.53 145-155.

9. Shah S.H., Patel J.K., Patel N.V. International Journal of Pharm Tech Research Coden (USA): IJPRIF ISSN: 0974- 4304vol.1, No.3, Pp 623-633, July-Sept 2009.

10. Tripathi, K.D., In: Essentials of medical pharmacology, 6th edition. JAYPEE Brothers Medical Publishers Ltd. New Delhi2008; pp. 214.

11. Nikita Dixit, Floating Drug Delivery System, J. Curr. Pharm. Res., 2011; 7(1):6-20

12. Pallavi Pal., Vijay Sharma., Lalit Singh., A Review on Floating type Gastroretentive Drug Delivery System, IRJP, 2012; 3(4): 37-43.

13. Banker GS, Rhodes CT. Modern Pharmaceutics. Marcel Dekker 1996; 3: 125-8.

14. Debjit Bhowmik., Chiranjib B., Margret Chandira., Jayakar B., Sampath Kumar K.P., Floating Drug Delivery System-A Review, Der Pharmacia Lettre, 2009; 1(2): 199-218.

15. Vyas S. P., Roop K. Khar., Controlled Drug Delivery: Concepts and Advances, Vallabh Prakashan, 196-217.

16. Gerogiannis V.S., Rekkas D.M., Dallas P.P., Choulis N.H., Floating and swelling characteristics of various excipients used in controlled release technology. Drug Dev. Ind. Pharm., 1993; 19: 1061 –1081.

17. Geetha A, Rajendra K, Krishna MC, Satish V, Raju PN. A review on: Floating drug delivery system. International Journal of Pharmaceutical Research and Biomedical Analysis; 2012; 1(1): 1 -13.

18. Talwar N, Himandri S, Ftaniforth KN. Orally administered controlled drug delivery system providing temporal and satial controlled. 2001; US Patent (6,261,601).

19. Y. S. Gattani, Floating Multiparticulate drug delivery systems: an overview, IJPBS Vol.1, (2010).

20. S.S. Davis, Drug Discovery Today: 2005; Vol.10: 249-256.

21. Stanley SD, Lisbeth I. Int J Pharm 1998; 176: 1 -8.

22. Baichwal, Anand K, Stanforth John N, Controlled release verapamil tablet, U.S.Patent-5, 169, 639, (1992).

23. Kawashima Y, T. Niwa, H. Takeuchi, T. Hino, Y. Itoh, Hollow microspheres for use as a floating controlled drug delivery system in the stomach; J of Pharm Sci. 1992; 81(2): 135-140.

24. Yie W. Chein “Novel Drug Delivery System” 2^nd ed. Marcel Jekker Inc., New York. 1992, 1-3.

25. Sanjay Garg and Shringi Sharma, “Gastroretentive drug delivery systems” Pharmatech 2003, 160-166.

26. Vedha Hari B.N.et al, the recent developments on gastric floating drug delivery systems: an overview Int. J. Pharmtech Res.2010, 2(1), 524-534.

27. Moya Nakagawa, Shin-Ichikonda, Yashuoi Sasai, Hasayuki Kuzuya, Preparation of floating drug delivery system by plasma technique, Chemical and Pharmaceutical bulletin (The Pharmaceutical society of Japan), 2006; 54(4514): 514-518.

28. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel Controlled release system for gastric retention. Pharm Res.1997; 14:815-819.

29. Przemyslaw Dorozynski, Piotr Kulinowski, Renata Jacob Wicz, Andrez Jasinski; Development of a system for simultaneous dissolution studies and magnetic resonance imaging of water transport in Hydrodynamically balanced systems: A technical note, AAPS Pharm SciTech, 2007; 8(1); E1 -E4.

30. Ichikawam, Watenables, and Miyake Y, “A multiple unit oral floating dosage systems preparation and in–vivo evaluation of floating and sustained release characteristics, J. Pharm. Sci, 1991; 80; 1062-1066.

31. Wu W, Zhou Q, Zhang HB, Ma GD, Fu CD. Studies on nimodipine sustained release tablet capable of floating on gastric fluids with prolonged gastric resident time. Yao Xue Xue Bao. 1997; 32:786Y790.

32. S. Arora, J. Ali, A. Ahuja, R. K. Khar and S. Baboota, Floating Drug Delivery Systems: A Review, AAPS Pharma. Scitech.2005; 6(3), E372-390.

33. G. M. Patel, H.R. Patel and M. Patel, Floating Drug Delivery System: An Innovative Approach to Prolong Gastric Retention. Pharmacoinfo.net (2007).

34. E. A. Klausner, E. Lavy and M. Friedman, Hofmann, Expandable Gastro Retentive Dosage Forms, J. Controlled Release, 2003; 90(2), 143-162.

35. B. Nath, L. K. Nath, B. Mazumdar, N. K. Sharma and M. K. Sarkar, Preparation and In Vitro Evaluation of Gastric Floating Microcapsules of Metformin HCl. Ind. J. Pharm. Educ. Res., 2009; 43(2), 177-186.

36. G. S. Asane, Mucoadhesive Gastrointestinal Drug Delivery System: An Overview (2007).

37. S. Baumgartner, K. Julijana, V. Franc, V. Polona and J. Bojon, Optimisation of Floating Matrix tablets and Evaluation of their Gastric Residence time, Int J. Pharm., 2000; 239(12), 81 - 91.

38. Natasha Sharma, Dilip Agarwal, and M.K. Gupta, A Comprehensive Review On Floating Drug Delivery System, International Journal Of Research In Pharmaceutical and Biomedical Sciences.2011; 2(2):123-134.

39. A. Geetha, J. Rajendra Kumar, Krishna Mohan, V. Sateesh and P.N. Raju, A Review On Floating Drug Delivery Systems, International Journal Of Pharmaceutical Research and Biomedical Analysis 2012; 1(1):1 -13.

40. S. Sarojinia R. Manavalan, An overview on various approaches to Gastro retentive dosage forms, International Journal of Drug Development and Research January-March 2012; 4 (1): 01-13.

41. Soppimath K.S, Kulkarni A.R, Aminabhavi T.M. In vitro and in vivo evaluation of Ranitidine hydrochloride ethyl cellulose floating microparticles, Drug Dev. Ind. Pharm, 2001; 27(6): 507- 515.

42. Rakesh Pahwa, Shiv Bhagwan. Role of Natural Polymers in the Development of Floating Drug Delivery Systems, Journal of Pharmacy Research 3 (2010) 1312-1318.

43. Deepak A. Dighe , Naresh H. Choudhary, Mangesh S. Thorat, Prasad R. Vir, Manoj S. Kumbhar And Meera C. Singh, Floating Drug Delivery System: A Novel Approach Towards Gastro Retention, International Journal Of Pharmaceutical And Chemical Sciences, Jul-Sep 2012; 1 (3); 89-96.

44. Nikita Dixit, Floating Drug Delivery System, Journal of Current Pharmaceutical Research 2011; 7 (1): 6- 20.

45. Angadi Sudha C., Manjeshwar Lata S., Aminabhavi Tejraj M., Novel composite blend microbeads of sodium alginate coated with chitosan for controlled release of amoxicillin, Int. J. Biol. Macromol., 2012; 50 (1-2): 45-55.

46. Prakya V., Vemula K.D., Devi K., Sonti S., Site-specific oral controlled release metformin tablets - development, in vitro, ex vivo and in vivo evaluation, The Internet Journal of Pharmacology, 2010; 8(1).

47. Yao Huimin. Yao Huijuan. Zhu Junyi., Yu Junlin., Zhang Lifan., Preparation and evaluation of a novel gastric floating alginate/poloxamer inner-porous beads using foam solution, Int. J. Pharm., 2012; 422 (1 -2): 211 -219.

48. Malakar Jadupati., Nayak Amit Kumar., Pal Dilipkumar. Development of cloxacillin loaded multiple-unit alginate based floating system by emulsion– gelation method, Int. J. Biol. Macromol., 2012; 50 (1): 138-147.

49. Nayak Amit Kumar., Das Biswarup., Maji Ruma., and Gastroretentive hydrodynamically balanced systems of Ofloxacin: In-vitro evaluation, Saudi Pharmaceutical Journal. In Press, Corrected Proof. DOI:10.1016/j.jsps.2011.11.002.

50. Mostafavi Abolfazl., Emami Jaber., Varshosaz Jaleh., Davies Neal M., Rezazadeh Mahboubeh., Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: Pharmacokinetic characterization in healthy human volunteers, Int. J. Pharm., 2011; 409 (1 -2): 128-136.

51. Işıklan Nuran., İnal Murat., Kurşun Fatma., Ercan Gülden., pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine, Carbohydrate Polymers, 2011; 84 (3): 933-943.

52. Dorożyński P., Kulinowski P., Mendyk A., Jachowicz R., Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose., Int. J. Pharm, 2011; 404 (1 -2): 169-175.

53. Liandong Hu., Li Li., Xun Yang., Wei Liu., Jianxue Yang., Yanhong Jia., Chuang Shang., Hongxin Xu., Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: In vitro and in vivo evaluation in healthy volunteers, Eur. J. Pharm. Sci., 2011; 42(1 –2): 99-105.

54. Mina Ibrahim Tadros., Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro–in vivo evaluation in healthy human volunteers, Eur. J. Pharm. Biopharm., 2010; 74(2): 332-339.

55. Aulton ME, Pharmaceutics: The Science of Dosage Form Design, International Student Edition, London, Churchill Livingstone (2002).

56. http://1.bp.blogspot.com/7T_jEV0aM40/UWe3NWWTzhI/AAAAAAAABDE/0wLjNf_RkqA/s1600/pharmatutor-art-1743-5.png

57. http://pharmatips.doyouknow.in/images/2013.08/Hydrodynamically-Balanced-Capsules-210836595456494.png

Received on 24.02.2015 Accepted on 15.03.2015

Asian J. Pharm. Res. 5(1): Jan.-Mar. 2015; Page 51-60

DOI: 10.5958/2231-5691.2015.00008.8

A Review: Floatable Gastroretentive Drug Delivery System

*Corresponding Author E-mail: snehawaghmare4@gmail.com